What is the significance and management of a 'tree in bud' appearance on computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tree-in-Bud Pattern on CT: Significance and Management

The tree-in-bud (TIB) pattern on CT scan most commonly represents infectious bronchiolitis with mucoid impaction of small airways, requiring a comprehensive evaluation to identify the underlying cause, particularly for infectious etiologies like nontuberculous mycobacteria. 1

Definition and Appearance

  • Tree-in-bud pattern refers to centrilobular nodules connected to linear branching structures that resemble a budding tree, representing dilated and inflamed bronchioles with mucoid impaction 1
  • This pattern is directly visible on high-resolution CT (HRCT) as small nodules (2-4mm) with linear branching abnormalities 1
  • TIB is typically seen in the peripheral lung regions and represents secondary manifestations of small airways disease 1

Clinical Significance and Etiology

Infectious Causes (Most Common)

  • Bacterial infections, particularly nontuberculous mycobacteria (NTM) like Mycobacterium avium complex (MAC) and tuberculosis 1
  • Approximately 67.5% of TIB patterns are associated with infectious etiologies 2
  • Pseudomonas aeruginosa and other bacterial pathogens in bronchiectasis 1
  • Fungal and viral respiratory infections 2

Non-infectious Causes

  • Aspiration pneumonia (10.4% of cases) 2
  • Malignancy (13.5% of cases), including central lung cancers causing bronchial obstruction 2, 3
  • Inflammatory disorders like diffuse panbronchiolitis (DPB) 1
  • Inflammatory bowel disease-related bronchiolitis 1
  • Drug-induced bronchiolitis (including inhaled substances like cocaine) 4
  • Rarely, hematologic malignancies like chronic lymphatic leukemia 5

Diagnostic Approach

Imaging

  • HRCT without IV contrast is the preferred initial imaging modality for evaluating TIB pattern 1
  • Look for associated findings that may suggest etiology:
    • Bronchiectasis or proximal airway wall thickening (present in 96% of TIB cases) 6
    • Mosaic attenuation on expiratory imaging (suggests air trapping) 1
    • Cavitary lesions (suggests mycobacterial infection) 1
    • Distribution pattern (focal vs. diffuse) 3

Microbiologic Evaluation

  • Sputum cultures for bacteria, mycobacteria, and fungi 1
  • If unable to produce sputum, consider induced sputum collection 1
  • Bronchoscopy with bronchial washing/lavage when sputum studies are non-diagnostic 1

Additional Testing

  • Pulmonary function tests to assess for obstructive pattern 1
  • Consider surgical lung biopsy when clinical, radiologic, and microbiologic findings are inconclusive 1

Management Algorithm

  1. Initial Assessment:

    • Determine if TIB pattern is focal/localized or diffuse/widespread 3
    • Evaluate for associated bronchiectasis, consolidation, or cavitary lesions 1, 6
  2. For Suspected Infectious Etiology (most common):

    • Obtain sputum cultures for bacteria, mycobacteria (at least two samples), and fungi 1
    • For suspected NTM infection, follow ATS/IDSA criteria for diagnosis:
      • Clinical criteria: pulmonary symptoms with nodular/bronchiectatic changes on CT
      • Microbiologic criteria: positive cultures from at least two separate sputum samples or one bronchial wash 1
    • For bacterial infections, appropriate antibiotic therapy based on culture results 1
  3. For Suspected Non-infectious Etiology:

    • If central obstruction is suspected, evaluate for malignancy 3
    • Consider bronchoscopy to exclude infection and evaluate for endobronchial lesions 1
    • In cases of suspected inflammatory disorders, assess for systemic conditions (e.g., inflammatory bowel disease) 1
  4. When Diagnosis Remains Unclear:

    • Perform bronchoscopy with bronchoalveolar lavage 1
    • Consider surgical lung biopsy for definitive diagnosis 1

Treatment Principles

  • For infectious bronchiolitis: prolonged antibiotic therapy targeted at the identified pathogen 1

    • For NTM (especially MAC): macrolide-based multi-drug regimen for 12+ months 1
    • For bacterial infections: appropriate antibiotics based on culture results 1
  • For non-infectious causes:

    • Cessation of exposure in toxic/drug-induced cases 1
    • Corticosteroids for inflammatory conditions 1
    • Treatment of underlying malignancy if present 3

Monitoring Response to Treatment

  • Serial sputum cultures every 4-12 weeks during treatment for mycobacterial infections 1
  • Follow-up CT scan to document radiological response after completing treatment 1
  • Monitor for clinical improvement in symptoms (cough, sputum production, fatigue) 1

Common Pitfalls and Caveats

  • TIB pattern may persist radiologically despite clinical improvement and microbiologic cure 1
  • Normal chest radiographs do not exclude TIB pattern due to limited resolution 1
  • Multiple etiologies may coexist, particularly in patients with underlying bronchiectasis 1
  • Not all TIB patterns represent active infection; consider non-infectious causes when cultures are repeatedly negative 2, 5
  • The presence of TIB pattern alone does not necessarily mandate treatment - clinical correlation is essential 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An unusual cause of 'tree-in-bud' appearance in CT-chest during COVID-19 pandemic.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020

Research

'Tree-in-bud': thinking beyond infectious causes.

Respiration; international review of thoracic diseases, 2015

Research

Tree-in-bud pattern: frequency and significance on thin section CT.

Journal of computer assisted tomography, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.